Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis
Irene Pastis, Melody G. Santos, Akshita Paruchuri
Frontiers in Behavioral Neuroscience (2024) Vol. 17
Open Access | Times Cited: 18

Showing 18 citing articles:

Microglial‐Biomimetic Memantine‐Loaded Polydopamine Nanomedicines for Alleviating Depression
Chaoqing Jiang, Xiao Yang, Qianqian Huang, et al.
Advanced Materials (2025)
Closed Access
New perspectives on galectin in major depressive disorder treatment
Laura Cabral Peixoto, Michelle Melgarejo da Rosa
Biochemical Pharmacology (2025) Vol. 233, pp. 116786-116786
Closed Access
The Anti-depression Effect and Mechanism of Harmonious Rosemary Essential Oil and its Application in Microcapsules
Yunwei Niu, Liyang Xu, Mu Qiao, et al.
Materials Today Bio (2025), pp. 101546-101546
Open Access
Molecular Regulation and Therapeutic Applications of Brain-Derived Neurotrophic Factor–Tropomyosin-Related Kinase B Signaling in Major Depressive Disorder Though Its Interaction with Vascular Endothelial Growth Factor and N-Methyl-D-Aspartic Acid Receptors: A Narrative Review
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia
Fengtao Guo, Lin Jing, Yunfan Xu, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
The Contribution of Genetic Testing in Optimizing Therapy for Patients with Recurrent Depressive Disorder
Rita Ioana Platona, Florica Voiță-Mekereș, Cristina Tudoran, et al.
Clinics and Practice (2024) Vol. 14, Iss. 3, pp. 703-717
Open Access | Times Cited: 3
Treatment-resistant depression: molecular mechanisms and management
Mayanja Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
MiRNA research—The potential for understanding the multiple facets of anorexia nervosa
Clara Voelz, Stefanie Trinh, Larissa Käver, et al.
International Journal of Eating Disorders (2024) Vol. 57, Iss. 7, pp. 1489-1494
Open Access | Times Cited: 2
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
Asmita Deka Dey, Ashi Mannan, Sonia Dhiman, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1491-1516
Closed Access | Times Cited: 2
Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
K. A. Vekhova, Evgeniya D. Namiot, Jörgen Jönsson, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 117, Iss. 2, pp. 374-386
Open Access | Times Cited: 2
Dual Approach to Depression: The Combined Efficacy of Intermittent Hypoxia and Fluoxetine in Modulating Behavioral and Inflammatory Responses
Francini Arboit, Gabriele Cheiran Pereira, Maria Fernanda Pessano Fialho, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2116-2116
Open Access | Times Cited: 1
Fructus Arctii Mitigates Depressive Disorder via the Let‐7e‐Modulated Toll‐Like Receptor (TLR) Signaling Pathway
Weifang Zhang, Qin Zhou
Brain and Behavior (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 1
On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.
Daniël Hoyer
Authorea (Authorea) (2024)
Open Access
Possible roles of neuropeptide/transmitter and autoantibody modulation in emotional problems and aggression
Henning Værøy, Regina Skar-Fröding, Elin Hareton, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression
Tahmineh Mokhtari, Fatemeh Sheikhbahaei, Maryam Saadat, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 245-274
Closed Access
In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor
Xiuqing Zhu, Yuexin Li, Huan Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Skin-brain dialogue in auto-inflammatory diseases: a new route to biomarkers?
Sara Matar, S. Aractingi, R. Gaillard, et al.
Brain Behavior & Immunity - Health (2024) Vol. 42, pp. 100906-100906
Open Access
Effects of Fzd6 on intestinal flora and neuroinflammation in lipopolysaccharide-induced depression-like mice
Wenlu Chen, Xiaoru Yan, Xiaona Song, et al.
Journal of Affective Disorders (2024) Vol. 372, pp. 160-172
Closed Access
Page 1

Scroll to top